Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP397674.RAivX9mEletr48VL692Bj2UA578gY4v-gXayWk-NpggY0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP397674.RAivX9mEletr48VL692Bj2UA578gY4v-gXayWk-NpggY0130_assertion type Assertion NP397674.RAivX9mEletr48VL692Bj2UA578gY4v-gXayWk-NpggY0130_head.
- NP397674.RAivX9mEletr48VL692Bj2UA578gY4v-gXayWk-NpggY0130_assertion description "[Also, the killing efficiency of CD16(+) lymphocytes was influenced by 158 V/F polymorphism of Fc gamma RIII (CD16), whereas variations of CD247 on NK cells were consistent with trends between ADCC before and after therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP397674.RAivX9mEletr48VL692Bj2UA578gY4v-gXayWk-NpggY0130_provenance.
- NP397674.RAivX9mEletr48VL692Bj2UA578gY4v-gXayWk-NpggY0130_assertion evidence source_evidence_literature NP397674.RAivX9mEletr48VL692Bj2UA578gY4v-gXayWk-NpggY0130_provenance.
- NP397674.RAivX9mEletr48VL692Bj2UA578gY4v-gXayWk-NpggY0130_assertion SIO_000772 18089830 NP397674.RAivX9mEletr48VL692Bj2UA578gY4v-gXayWk-NpggY0130_provenance.
- NP397674.RAivX9mEletr48VL692Bj2UA578gY4v-gXayWk-NpggY0130_assertion wasDerivedFrom befree-20140225 NP397674.RAivX9mEletr48VL692Bj2UA578gY4v-gXayWk-NpggY0130_provenance.
- NP397674.RAivX9mEletr48VL692Bj2UA578gY4v-gXayWk-NpggY0130_assertion wasGeneratedBy ECO_0000203 NP397674.RAivX9mEletr48VL692Bj2UA578gY4v-gXayWk-NpggY0130_provenance.